Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Primary vs Secondary Retrograde Approach in CTO: Differences

Successful chronic total occlusion procedures are on the rise, especially in high volume centers, seeing as they count on more sophisticated materials and different techniques, such the retrograde approach. However, the significant increase of success rate with this technique has also brought along an increase in associated complications. 

Abordaje Retrógrado en CTO: diferencias en el intento primario vs secundario

The aim of this study was to assess the frequency and end point of primary vs secondary retrograde approach. 

The PROGRESS-CTO registry was used. Primary retrograde approach was defined as cases where the first attempt at crossing was retrograde, while secondary approach was defined as crossing after failed antegrade approach. 

Data from 2789 patients were obtained; mean age was 64.8, and 85% were men. The retrograde approach was used as primary strategy in 1086 of cases (38.9%), while the secondary approach, after failed first antegrade attempt, was seen in 1703 cases (61.1%). Patients in the primary group had higher CABG rate (52.9%vs38.4%; P<0.001). The artery most frequently affected was the right coronary (71%), score PROGRESS-CTO was higher in the primary group.

Secondary approach interventions lasted more (180 min vs 175 min), received more kerma radiation (1.8 Gy vs 1.4 Gy) and more contrast (270ml vs 250ml). Both technical and procedural success rate (81.4% vs 77.3%; P<0.001 and 78.6% vs 74.1%, P<0.001 respectively) were significantly higher in the primary group. 

Read also: Is the Cause of Mitral Regurgitation Relevant for MitraClip?

In-hospital major cardiovascular adverse events rate (MACE) was comparable in both groups (4.3% vs 4%; P=0.66), and in-hospital death rate was low with both strategies. There were no significant differences in new revascularization rate (0.37% vs 0.59%; P=0.43), stroke (0.4% vs 0.2%; P=0.52) or perforation (8.8% vs 10.7%; P=0.11).

Conclusions

It was observed, in an important number of patients, that primary retrograde approach presented a higher technical success rate, as well as procedural, vs. the secondary approach. The retrograde approach can be the first choice of treatment in some cases, especially long CTO procedures, with tortuous occlusions and an ambiguous proximal cap. These results do not apply to all CTO cases, where we know the approach should be antegrade. 

Dr. Omar Tupayachi

Dr. Omar Tupayachi.
Member of the Editorial Board of SOLACI.org.

Original title: Primary vs Secondary Retrograde Approach in Chronic Total Occlusion Percutaneous Coronary Interventions.

Source: Kostantinis, Spyridon et al. “Primary vs Secondary Retrograde Approach in Chronic Total Occlusion Percutaneous Coronary Interventions.” The Journal of invasive cardiology vol. 34,9 (2022): E672-E677.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...